• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES ANTI-KAPPA PE CE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES ANTI-KAPPA PE CE Back to Search Results
Catalog Number 347246
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/05/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using anti-kappa pe ce, user discovered contamination.The following information was provided by the customer: found due to field corrective action emea bdb-22-4384a anti kappa contamination with cd8 pe antibody.Due to fca customer checked analysis performed with this product.Confirmed described contamination for analyzed patient samples, but without impact on patient diagnosis and treatment.
 
Event Description
It twas reported that while using anti-kappa pe ce user discovered contamination.The following information was provided by the customer: found due to field corrective action emea bdb-22-4384a anti kappa contamination with cd8 pe antibody.Due to fca customer checked analysis performed with this product.Confirmed described contamination for analyzed patient samples, but without impact on patient diagnosis and treatment.
 
Manufacturer Narrative
H6 investigation summary: bd acknowledges the customer¿s experience regarding the indicated failure mode of contamination with the reported reagent material # 347246 batch 1284407.A review of the manufacturing records was completed for the reagent.The claim was confirmed and communicated as part of field corrective action bdb-22-4384 fa for anti kappa contamination with cd8 pe and actions taken as part of capa4453779.Bd is continually monitoring complaints received for this device and reported issues to identify emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTI-KAPPA PE CE
Type of Device
NA
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
2350 qume drive
san jose CA 95131
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15253715
MDR Text Key301292641
Report Number2916837-2022-00223
Device Sequence Number1
Product Code MVU
Combination Product (y/n)N
Reporter Country CodePL
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/31/2023
Device Catalogue Number347246
Device Lot Number1284407
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/21/2022
Initial Date FDA Received08/18/2022
Supplement Dates Manufacturer Received12/12/2022
Supplement Dates FDA Received12/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/21/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-